Speaker illustration

Doctor Jaya Birgitte Rosenmeier

AstraZeneca, Gothenburg (Sweden)

Safety, tolerability, and pharmacokinetics of AZD5462, a small molecule agonist of the RXFP1 relaxin receptor

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Experimental therapies for heart failure

Thumbnail